Health Care & Life Sciences » Pharmaceuticals | Korean Drug Co. Ltd.

Korean Drug Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
41,555
45,392
47,391
55,308
55,403
Cost of Goods Sold (COGS) incl. D&A
25,670
27,697
27,970
32,888
32,821
Gross Income
15,885
17,695
19,421
22,420
22,582
SG&A Expense
14,850
14,858
16,284
15,795
16,682
EBIT
1,035
2,837
2,535
5,964
5,299
Unusual Expense
-
451
-
-
942
Non Operating Income/Expense
101
60
182
143
1,094
Interest Expense
389
290
126
52
26
Pretax Income
788
2,199
2,609
6,067
5,432
Income Tax
79
47
835
1,016
748
Consolidated Net Income
709
2,151
1,774
5,050
4,683
Net Income
709
2,151
1,774
5,050
4,683
Net Income After Extraordinaries
709
2,151
1,774
5,050
4,683
Net Income Available to Common
709
2,151
1,774
5,050
4,683
EPS (Basic)
65.00
198.00
162.00
463.00
429.00
Basic Shares Outstanding
11
11
11
11
11
EPS (Diluted)
64.51
197.61
162.32
462.56
429.15
Diluted Shares Outstanding
11
11
11
11
11
EBITDA
1,990
3,803
3,499
6,885
6,253
Other Operating Expense
-
-
602
662
601
Non-Operating Interest Income
40
42
18
12
8

About Korean Drug Co.

View Profile
Address
69-10 Wonjeok-ro
Icheon GY 17303
Korea, Republic Of
Employees -
Website http://www.nicepharma.com
Updated 09/14/2018
Korean Drug Co., Ltd. engages in the research and development, manufacture and sale of pharmaceutical products. Its products are divided into the following categories: Over-The-Counter (OTC), ETC and Health Foods. Its products include remedies for respiratory diseases, topical agents for dermatoses, antibiotics and chemotherapeutics, hypnotics, antiulcer agents, antihistaminic, amino acid nutrients, antifungal agents and home pregnancy test kit.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.